» Articles » PMID: 37831380

Total Glucosides of Paeony Ameliorate Myocardial Injury in Chronic Heart Failure Rats by Suppressing PARP-1

Overview
Publisher Springer
Date 2023 Oct 13
PMID 37831380
Authors
Affiliations
Soon will be listed here.
Abstract

Total glucosides of paeony (TGP) have a potential protective effect on chronic heart failure (CHF) rats, but the mechanism remains unclear. PARP inhibition prevents the decrease in myocardial contractility. Therefore, we aim to investigate the effects and mechanisms of TGP on CHF and the role of PARP-1 in CHF. Left anterior descending ligation rats and adriamycin-treated H9C9 cells were used as CHF models, and captopril as a positive control for in vivo experiments. We found that TGP alleviated myocardial remodeling and improved cardiac morphology and function. TGP also reduced myocardial apoptosis and autophagy, decreased inflammatory factor release, and inhibited the PARP-1 and NF-κB proteins. Through cell transfection, we found that PAPR-1 knockdown inhibited NF-κB nuclear translocation. Additionally, TGP inhibited apoptosis, autophagy, and inflammation in CHF cells, while PARP-1 overexpression partially antagonized them. In conclusion, TGP has the potential to improve CHF and PARP-1 may be a potential target.

Citing Articles

Pharmacological and toxicological effects of Jiangfangbaoxin and determination of its components in the blood of spontaneously hypertensive rats.

Shi Z, Wang Q, Jia F, Li Q, Lu S Sci Rep. 2025; 15(1):4934.

PMID: 39929910 PMC: 11811156. DOI: 10.1038/s41598-025-88009-0.


Total Glycosides of Paeony Activates PI3K/Akt Pathway to Alleviate Cardiomyocyte Hypertrophy Induced by AngII.

Sheng L, Shen M, Shao D Cell Biochem Biophys. 2025; .

PMID: 39821826 DOI: 10.1007/s12013-024-01616-y.


Exploring the therapeutic mechanisms of heart failure with Chinese herbal medicine: a focus on miRNA-mediated regulation.

Wang Y, Lai J, Chen Z, Sun L, Ma Y, Wu J Front Pharmacol. 2024; 15:1475975.

PMID: 39564110 PMC: 11573571. DOI: 10.3389/fphar.2024.1475975.


Targeting Macrophage Phenotype for Treating Heart Failure: A New Approach.

Shi M, Yuan H, Li Y, Guo Z, Wei J Drug Des Devel Ther. 2024; 18:4927-4942.

PMID: 39525046 PMC: 11549885. DOI: 10.2147/DDDT.S486816.


Bone marrow mesenchymal stem cells-derived exosomal lncRNA GAS5 mitigates heart failure by inhibiting UL3/Hippo pathway-mediated ferroptosis.

Ren Y, Zhao X Eur J Med Res. 2024; 29(1):303.

PMID: 38812041 PMC: 11137962. DOI: 10.1186/s40001-024-01880-x.

References
1.
Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska A . Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int J Mol Sci. 2021; 22(7). PMC: 8038770. DOI: 10.3390/ijms22073789. View

2.
Sayer G, Bhat G . The renin-angiotensin-aldosterone system and heart failure. Cardiol Clin. 2013; 32(1):21-32, vii. DOI: 10.1016/j.ccl.2013.09.002. View

3.
Wen J, Zhang L, Liu H, Wang J, Li J, Yang Y . Salsolinol Attenuates Doxorubicin-Induced Chronic Heart Failure in Rats and Improves Mitochondrial Function in H9c2 Cardiomyocytes. Front Pharmacol. 2019; 10:1135. PMC: 6797600. DOI: 10.3389/fphar.2019.01135. View

4.
Upadhya B, Kitzman D . Heart failure with preserved ejection fraction: New approaches to diagnosis and management. Clin Cardiol. 2019; 43(2):145-155. PMC: 7021648. DOI: 10.1002/clc.23321. View

5.
Peng X, Wang Y, Li H, Fan J, Shen J, Yu X . ATG5-mediated autophagy suppresses NF-κB signaling to limit epithelial inflammatory response to kidney injury. Cell Death Dis. 2019; 10(4):253. PMC: 6420665. DOI: 10.1038/s41419-019-1483-7. View